Stratec SE SBS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €43.35
- Day Range
- €43.05–43.75
- 52-Week Range
- €36.00–69.00
- Bid/Ask
- €43.40 / €43.60
- Market Cap
- €531.21 Mil
- Volume/Avg
- 2,914 / 8,634
Key Statistics
- Price/Earnings (Normalized)
- 31.29
- Price/Sales
- 2.09
- Dividend Yield (Trailing)
- 2.24%
- Dividend Yield (Forward)
- 1.27%
- Total Yield
- 2.24%
Company Profile
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,473
- Website
- https://www.stratec.com
Comparables
Valuation
|
Metric
|
SBS
|
300832
|
688468
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.29 | 37.09 | 25.11 |
Price/Book Value | 2.30 | 7.60 | 2.18 |
Price/Sales | 2.09 | 14.85 | 6.57 |
Price/Cash Flow | 20.70 | 40.33 | 15.55 |
Price/Earnings
SBS
300832
688468
Financial Strength
|
Metric
|
SBS
|
300832
|
688468
|
|---|---|---|---|
Quick Ratio | 0.80 | 7.03 | 4.92 |
Current Ratio | 2.32 | 9.39 | 5.69 |
Interest Coverage | 4.50 | 4,287.59 | 243.98 |
Quick Ratio
SBS
300832
688468
Profitability
|
Metric
|
SBS
|
300832
|
688468
|
|---|---|---|---|
Return on Assets (Normalized) | 3.60% | 20.86% | 8.96% |
Return on Equity (Normalized) | 6.92% | 22.61% | 11.16% |
Return on Invested Capital (Normalized) | 5.29% | 22.45% | 9.70% |
Return on Assets
SBS
300832
688468
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pskfbzf | Xfhvp | $182.3 Bil | |
SYK
| Stryker Corp | Qgqmgwbxg | Xynpl | $123.5 Bil | |
MDT
| Medtronic PLC | Lqbwzvqgk | Ghvmjvs | $111.9 Bil | |
BSX
| Boston Scientific Corp | Jmwxsjnp | Kgdpx | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Chrtsmwfs | Ltrrjr | $52.1 Bil | |
DXCM
| DexCom Inc | Gdcpgyhmg | Ljyvg | $49.5 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Nrmqnmlb | Sylz | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Rfgpdpmv | Psynds | $24.5 Bil | |
ALGN
| Align Technology Inc | Gxdnknhv | Tgclyy | $20.5 Bil | |
PODD
| Insulet Corp | Psbxnvvxz | Swlcxzy | $11.3 Bil |